EBC was pleased to be part of this year’s Congress of the European Academy of Neurology, which took place in person on 25-28 June 2022 in Vienna, Austria. Alongside an Exhibition Stand in the EAN Neurohood, EBC had a Special Session take place on 28 June at 13:00-14:30 (Room Berlin), celebrating 20 Years of Advocacy for the Brain. The session featured the following presentations:

Introduction & Moderation by Prof. Wolfgang Oertel, President, European Brain Council
History of the European Brain Council by Prof. Jes Olesen, Founding President, European Brain Council
Involving patients and the Value of Treatment by Joke Jaarsma, Treasurer, European Brain Council and President, European Federation of Neurological Associations
Advocating for the brain: the European Brain Research Area by Frédéric Destrebecq, Executive Director, European Brain Council

Additionally, EBC projects such as the European Brain Research Area (EBRA) and the Value of Treatment were showcased at the congress in the Scientific Theatre and through ePosters.

Scientific Theatres:
– EBC Value of Treatment (VOT) Study – Bridging gaps and achieving seamless, coordinated care, a study on rare neurological and neurometabolic disorders by the European Brain Council – 25 June 2022, 14:00 – 14:30 (Theatre 09)
– EBC Value of Treatment (VOT) Study – A Comparison of Optimal Management vs Current Management of Chronic Pain– 27 June 2022, 10:00-10:30 (Theatre 25)
– European Brain Research Area (EBRA): Outcome and results of the Horizon 2020 project – 28 June 2022, 10:30-11:00 (Theatre 37)

ePosters:
– EBC Value of Treatment (VOT) Study – A Comparison of Optimal Management vs Current Management of Chronic Pain – 26 June 2022, 12:30 to 13:15 (Screen B7)
– EBC Value of Treatment (VOT) Study – Assessing the Value of Specialist Centres for the Diagnosis and Management of the Ataxias in Europe – 26 June 2022, 12.30-13.15 (Screen A9)

The post EBC at EAN Congress 2022 appeared first on European Brain Council (EBC).

The annual European College of Neuropsychopharmacology (ECNP) Congress is Europe’s premier scientific meeting for disease-oriented brain research, annually attracting more than 5,000 psychiatrists, neuroscientists, neurologists and psychologists from around the world.

The European College of Neuropsychopharmacology (ECNP) is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe.

EBC was pleased to take part in the ECNP Congress which took place on 15-18 October 2022 in Vienna (Austria) and virtually. Alongside an Exhibition Stand in the exhibition area (booth 16), EBC had a campfire session The value of early intervention and continuity of care for mental disorders take place on 17 October at 11:15 – 12:00. The session, moderated by Prof. Judit Simon, featured the following presentations:

• The value of early intervention for associated epilepsy in autism by Prof. Celso Arango, Spain
• The value of early intervention and continuity of care for mood disorders by Prof. Allan Young, United Kingdom

Additionally, the EBC project the European Brain Research Area (EBRA) was showcased at the congress through a poster.

We look forward to the next year’s congress which will take place from 7-10 October 2023 in Barcelona (Spain)!

The post EBC at the 35th European College of Neuropsychopharmacology (ECNP) Congress appeared first on European Brain Council (EBC).